A medicine made for every person.

The first person penicillin ever saved died anyway. The medicine worked. Making it failed.

Eighty-five years later, we can rewrite the DNA in a dying patient's own cells. It costs $2.2 million a dose (Casgevy). That cost is not the discovery. It is the making — running a living process, then proving it ran exactly right: every step recorded, reviewed, and signed by hand.

A drug made for millions proves the process once. A medicine made for one proves it again for every patient — which is why it reaches only dozens.

The problem is not money, or talent. It is proof. Proof does not scale, so the cure can exist and the person who needs it die anyway.

You cannot predict a living process from theory — you measure it, run after run, until you can. So we built one system that holds the whole of it, where the making and the proving are one act, read by an intelligence trained on that record and nothing else. A medicine is simulated before it is made, and proven in the making, at a marginal cost of zero.

The decade of proving collapses to the days of making. For a million people, or for one.

Until there is a medicine made for every person.